IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’

On CNBC’s “ Halftime Report Final Trades,” Jim Lebenthal, partner and chief market strategist at Cerity Partners, said Vertex Pharmaceuticals Inc (NASDAQ: VRTX ) is a great name to own in the health care sector. As per the recent news, Vertex Pharmaceuticals, on June 11, reported new clinical data showing that CASGEVY (exagamglogene autotemcel) delivered efficacy and safety outcomes in children ages 5 to 11 with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The data were consistent with results previously observed in adolescent and adult patients. Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, picked Verizon Communications Inc (NYSE: VZ ), which recorded losses on Monday. The stock has a 6.5% dividend yield, she added. Verizon Communications shares tumbled on Monday after the company disclosed...